Apollon Wealth Management LLC Has $15.26 Million Stock Position in Procter & Gamble Company (The) $PG

Key Points

• Apollon Wealth Management LLC has reduced its position in Procter & Gamble by 2.0%, owning approximately $15.26 million worth of shares after selling 1,974 shares in the latest quarter.
• Procter & Gamble reported earnings of $1.48 EPS, surpassing analysts' expectations of $1.42, with revenues reaching $20.89 billion for the quarter.
• Several institutional investors are actively adjusting their stakes in Procter & Gamble, with institutional ownership now at 65.77% of the stock.

Apollon Wealth Management LLC reduced its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 2.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,809 shares of the company's stock after selling 1,974 shares during the period. Apollon Wealth Management LLC's holdings in Procter & Gamble were worth $15,264,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the company. Nova Wealth Management Inc. bought a new position in shares of Procter & Gamble in the 1st quarter valued at $26,000. Signature Resources Capital Management LLC lifted its stake in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock valued at $28,000 after acquiring an additional 72 shares during the last quarter. Quarry LP bought a new position in shares of Procter & Gamble in the 1st quarter valued at $33,000. Mizuho Securities Co. Ltd. lifted its stake in shares of Procter & Gamble by 566.7% in the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after acquiring an additional 170 shares during the last quarter. Finally, RMG Wealth Management LLC bought a new position in shares of Procter & Gamble in the 2nd quarter valued at $37,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

PG stock opened at $149.69 on Friday. Procter & Gamble Company has a 1-year low of $149.45 and a 1-year high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The stock has a 50-day moving average price of $155.24 and a 200-day moving average price of $159.48. The firm has a market cap of $350.34 billion, a PE ratio of 22.99, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same quarter in the prior year, the company earned $1.40 EPS. The firm's revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Wall Street Analyst Weigh In

PG has been the subject of a number of research reports. Berenberg Bank increased their price target on Procter & Gamble from $152.00 to $154.00 and gave the company a "hold" rating in a research note on Wednesday, September 17th. Wells Fargo & Company dropped their price target on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a research note on Thursday, September 25th. Bank of America decreased their price objective on Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a report on Wednesday. BNP Paribas Exane decreased their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a report on Tuesday, September 23rd. Finally, Weiss Ratings restated a "hold (c+)" rating on shares of Procter & Gamble in a report on Wednesday. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $172.21.

Insider Activity at Procter & Gamble

In related news, COO Shailesh Jejurikar sold 3,986 shares of the company's stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the sale, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. This represents a 7.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Andre Schulten sold 4,252 shares of the company's stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $647,281.96. Following the sale, the chief financial officer owned 53,992 shares in the company, valued at approximately $8,219,202.16. The trade was a 7.30% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 over the last quarter. 0.20% of the stock is owned by company insiders.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.